LB PHARMACEUTICALS INC
Q3 2026 13F Holders
Symbol
LBRX
CUSIP
50180M108
Type
Equity
Class
COM SHS
Num filings
19
Total reported value, excl. options
$5.27 M
Compare 2026 Q3 to
2026 Q2
2026 Q1
2025 Q4
2025 Q3
Manager
Report Date
Value ($000)
Shares
Option Type